Veterinary protocol for cellular regeneration

Abstract

A medicament and corresponding treatment protocol for in-vivo cellular regeneration within a mammal is described. Applications include the treatment of injuries to bone, cartilage, ligaments and tendons in humans and animals. Treatment includes the step of administering one or more therapeutically effective doses of medicament into an injured, living mammal. For the treatment, the medicament includes a plurality of stem cells and an angiogenic factor such as vascular endothelial growth factor (VEGF). In one implementation, non-embryonic stem cells are harvested from the mammal after injury for use in the medicament. Once harvested, the stem cells are typically concentrated (by removing non-stem cells from the harvested cell population) in a laboratory and then mixed with angiogenic factor to prepare the medicament. In an exemplary procedure, approximately ten therapeutically effective doses are injected into the body at or near the injured tissue during a healing period following the injury.

Dependencies are inferred from the claim text.